Dr. Haney is a biomedical engineer and has been working on multi-modality imaging for the past ten years. With multiple collaborators he has been attempting to identify a signature for successful treatment of a novel anti-vascular treatment using Magnetic Resonance Imaging (MRI) and Electron Paramagnetic Resonance Imaging (EPRI). He was recently awarded an R03 to use histology and image registration to further this project. In a similar project, Dynamic Contrast Enhanced MRI (DCE-MRI) was used to assess the response to an anti-angiogenic drug that is now on the market. Both projects are being used to develop new DCE-MRI analysis methods.
He is also expanding his multi-modality imaging background by using Single Photon Emission Computed Tomography (SPECT) to detect insulinomas in transgenic mice. Registration of MRI of the pancreas will guide interpretation of the SPECT images. Another nuclear imaging project uses Positron Emission Tomography (PET) with Computed Tomography (CT) to try to detect early stages of mediastinal tumors in transgenic mice.